Back to B. Metzler seel. Sohn & Co. AG B. Metzler seel. Sohn & Co. AG

HALOHALO
10 quarters

Position history for B. Metzler seel. Sohn & Co. AGB. Metzler seel. Sohn & Co. AG's holdings in HALOZYME THERAPEUTICS INC

B. Metzler seel. Sohn & Co. AG previously held 0 shares of HALO (HALOZYME THERAPEUTICS INC), worth $0 as of 2025-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$1.3M

Total Shares Change

-32,783

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$52.21
0
2025-Q1
Unchanged
23,096
0.0%
$1.5M0.0%$63.84
0
2024-Q4
Decreased
23,096
-30.4%
$1.1M0.0%$47.99
0
2024-Q3
Decreased
33,183
-21.8%
$1.9M0.0%$56.97
0
2024-Q2
Unchanged
42,435
0.0%
$2.2M0.0%$52.36
0
2024-Q1
Unchanged
42,435
0.0%
$1.7M0.0%$40.68
0
2023-Q4
Increased
42,435
+12.8%
$1.6M0.0%$36.96
29
2023-Q3
Decreased
37,627
-46.6%
$1.4M0.0%$38.20
0
2023-Q2
Increased
70,508
+115.1%
$2.5M0.0%$34.67
42
2023-Q1
New
32,783
-
$1.3M0.0%$37.31
35

Other major holders of HALO: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used